The antibody contract manufacturing market is estimated to be worth USD 17 billion in 2030

By: Roots Analysis
CALIFORNIA CITY, Calif. - Feb. 16, 2021 - PRLog -- The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new technologies and operational flexibility are attractive attributes to larger players as well

Roots Analysis ( is pleased to announce the publication of its recent study, titled, "Antibody Contract Manufacturing Market, 2020-2030 (" report to its list of offerings.

Key companies covered in the report (

§  AGC Biologics

§  Aldevron


§  Boehringer Ingelheim BioXcellence

§  Emergent BioSolutions

§  Eurofins CDMO

§  FUJIFILM Diosynth Biotechnologies

§  KBI Biopharma

§  Lonza

§  Nitto Avecia Pharma Services

§  Novasep

§  Pierre Fabre

§  Samsung BioLogics

§  Synthon

§  Thermo Fisher Scientific

For more information please click on the following link:

Other Recent Offerings

1.     Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030

2.     Antibody Drug Conjugates (ADCs) - Linker and Conjugation Technologies Market, 2019-2030

3.     Antibody Drug Conjugates Market (5th Edition), 2019-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you'd like help with your growing business needs, get in touch at

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415
Location:California City - California - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
nnn PRs
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share